Publications

A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing

Côté J, Auger P, Chicoine G, Cheng J, Cossette S, Fontaine G, Genest C, Lal S, Lapierre J, Pagé MG, Maheu-Cadotte MA, Rouleau G, Vinette B, Jutras-Aswad D. JMIR Form Res. 2025 Jun 23;9:e71924. doi: 10.2196/71924. PMID: 40550117; PMCID: PMC12235202. CONSULTER

A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing Lire la suite »

Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder

Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D. Can J Psychiatry. 2025 Aug 28:7067437251367180. doi: 10.1177/07067437251367180. Epub ahead of print. PMID: 40874578; PMCID: PMC12394192 CONSULTER

Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder Lire la suite »

A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States

Zolopa C, Clifasefi SL, Dobischok S, Gala N, Fraser-Purdy H, Phillips MK, Blackmore S, Wendt DC. Drug Alcohol Depend. 2025 Apr 1;269:112597. doi: 10.1016/j.drugalcdep.2025.112597. Epub 2025 Feb 12. PMID: 39970577. CONSULTER

A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States Lire la suite »

The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial

McAnulty C, Bastien G, Abboud A, Bahremand A, Ledjiar O, Socias ME, Le Foll B, Juteau LC, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. J Subst Use Addict Treat. 2025 Sep;176:209743. doi: 10.1016/j.josat.2025.209743. Epub 2025 Jun 24. PMID: 40571059. CONSULTER

The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial Lire la suite »